Follow the 지엘팜텍 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 지엘팜텍 has recorded 14 reports. Market capitalisation: €63.1bn. The latest transaction was disclosed on 19 June 2026 (Other). Among the most active insiders: 지엘팜텍. All data is openly available.
14
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
4 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,878 of 29,062 companies
23.0
score / 100
Value
17
Quality
29
FCF yld-7.5%
Earn yld0.0%
EV/EBITDA55.9x
ROE-0.7%
Gross mgn41%
Net mgn0.0%
Debt/EBITDA11.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.